Healthcare -
Biotechnology - NASDAQ - US
$ 3.79
49.2 %
$ 10.3 M
Market Cap
-1.82
P/E
CYCN - STOCK-BASED COMPENSATION
Stock-based Compensation CYCN - Cyclerion Therapeutics, Inc.
1.07 M
LAST VALUE
-66.68%
2 YEAR CAGR
-38.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR